Insider Trading activities of Forty Seven, Inc. (FTSV)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Forty Seven, Inc. (FTSV) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Forty Seven, Inc. since year 2005. Table 2 shows the detailed insider transactions of Forty Seven, Inc. since 2005. The reporting company's ticker symbol is FTSV. The reporting company's CIK number is 1667633.
The total value of stock buying since 2005 is $41,665,811.
The total value of stock sales since 2005 is $8,395,767.
The total value of stock option exercises since 2005 is $811,519.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Forty Seven, Inc. (FTSV).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-05 0 $0 28,811 $415,367 24,500 $96,689
2019-04 0 $0 79,400 $1,424,074 24,500 $96,689
2019-03 0 $0 73,216 $1,282,129 24,500 $96,689
2019-02 0 $0 226,233 $3,612,768 24,500 $96,689
2019-01 0 $0 85,699 $1,312,975 79,687 $366,167
2018-12 0 $0 22,000 $348,454 12,000 $58,596
2018-08 300,900 $4,540,291 0 $0 0 $0
2018-07 2,320,345 $37,125,520 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Forty Seven, Inc. insiders (FTSV)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-05-20 Mccamish Mark Anthony (President and CEO) Sale 16,500 12.27 202,372
2019-05-20 Mccamish Mark Anthony (President and CEO) Option Ex 16,500 4.88 80,569
2019-05-16 Majeti Ravindra (Director) Sale 2,088 16.02 33,460
2019-05-15 Majeti Ravindra (Director) Sale 2,223 16.01 35,583
2019-05-03 Takimoto Chris H (Chief Medical Officer) Sale 8,000 17.99 143,952
2019-05-03 Takimoto Chris H (Chief Medical Officer) Option Ex 8,000 2.02 16,120
2019-04-26 Weissman Irving (Director) Sale 20,000 18.35 366,980
2019-04-18 Mccamish Mark Anthony (President and CEO) Sale 16,500 18.12 299,062
2019-04-18 Mccamish Mark Anthony (President and CEO) Option Ex 16,500 4.88 80,569
2019-04-15 Majeti Ravindra (Director) Sale 25,000 18.30 457,500
2019-04-05 Weissman Irving (Director) Sale 6,518 17.15 111,796
2019-04-04 Takimoto Chris H (Chief Medical Officer) Sale 8,000 16.39 131,104
2019-04-04 Takimoto Chris H (Chief Medical Officer) Option Ex 8,000 2.02 16,120
2019-04-03 Weissman Irving (Director) Sale 3,382 17.04 57,632
2019-03-29 Weissman Irving (Director) Sale 100 18.00 1,800
2019-03-26 Weissman Irving (Director) Sale 10,000 15.98 159,810
2019-03-19 Majeti Ravindra (Director) Sale 5,292 18.03 95,398
2019-03-19 Mccamish Mark Anthony (President and CEO) Sale 16,500 18.15 299,409
2019-03-19 Mccamish Mark Anthony (President and CEO) Option Ex 16,500 4.88 80,569
2019-03-18 Majeti Ravindra (Director) Sale 9,708 18.02 174,938
2019-03-15 Majeti Ravindra (Director) Sale 20,000 17.68 353,620
2019-03-04 Takimoto Chris H (Chief Medical Officer) Sale 8,000 16.94 135,552
2019-03-04 Takimoto Chris H (Chief Medical Officer) Option Ex 8,000 2.02 16,120
2019-03-01 Weissman Irving (Director) Sale 3,616 17.04 61,602
2019-02-27 Weissman Irving (Director) Sale 4,280 17.01 72,807
2019-02-26 Weissman Irving (Director) Sale 12,104 16.93 204,969
2019-02-25 Majeti Ravindra (Director) Sale 30,798 16.07 494,985
2019-02-25 Weissman Irving (Director) Sale 10,000 17.03 170,330
2019-02-22 Majeti Ravindra (Director) Sale 67,113 16.01 1,074,411
2019-02-20 Mccamish Mark Anthony (President and CEO) Sale 9,410 14.94 140,547
2019-02-20 Mccamish Mark Anthony (President and CEO) Option Ex 9,410 4.88 45,949
2019-02-19 Takimoto Chris H (Chief Medical Officer) Sale 2,500 15.05 37,622
2019-02-19 Mccamish Mark Anthony (President and CEO) Sale 7,090 15.06 106,796
2019-02-19 Mccamish Mark Anthony (President and CEO) Option Ex 7,090 4.88 34,620
2019-02-04 Takimoto Chris H (Chief Medical Officer) Sale 8,000 14.86 118,872
2019-02-04 Takimoto Chris H (Chief Medical Officer) Option Ex 8,000 2.02 16,120
2019-02-04 Weissman Irving (Director) Sale 6,445 15.02 96,803
2019-02-01 Weissman Irving (Director) Sale 3,219 15.02 48,362
2019-01-31 Majeti Ravindra (Director) Sale 3,834 14.57 55,872
2019-01-30 Majeti Ravindra (Director) Sale 16,166 14.46 233,679
2019-01-28 Weissman Irving (Director) Sale 336 15.00 5,040
2019-01-25 Mccamish Mark Anthony (President and CEO) Option Ex 51,687 4.88 252,387
2019-01-18 Mccamish Mark Anthony (President and CEO) Sale 20,000 14.60 291,900
2019-01-18 Mccamish Mark Anthony (President and CEO) Option Ex 20,000 4.88 97,660
2019-01-16 Majeti Ravindra (Director) Sale 4,363 16.00 69,821
2019-01-15 Majeti Ravindra (Director) Sale 23,000 15.73 361,813
2019-01-09 Weissman Irving (Director) Sale 10,000 17.05 170,490
2019-01-04 Takimoto Chris H (Chief Medical Officer) Sale 8,000 15.54 124,360
2019-01-04 Takimoto Chris H (Chief Medical Officer) Option Ex 8,000 2.02 16,120
2018-12-26 Mccamish Mark Anthony (President and CEO) Sale 12,000 15.90 190,764
2018-12-26 Mccamish Mark Anthony (President and CEO) Option Ex 12,000 4.88 58,596
2018-12-26 Weissman Irving (Director) Sale 10,000 15.77 157,690
2018-08-23 Mhatre Ravi (10% Owner) Buy 56,858 15.27 868,278
2018-08-22 Mhatre Ravi (10% Owner) Buy 110,000 14.97 1,647,140
2018-08-17 Nieh Peter (10% Owner) Buy 2,500 14.96 37,400
2018-08-16 Nieh Peter (10% Owner) Buy 65,000 15.19 987,480
2018-08-16 Schaepe Christopher J (Director) Buy 66,542 15.03 999,993
2018-07-02 Liew Jeremy (10% Owner) Buy 468,750 16.00 7,500,000
2018-07-02 Pullara Samuel J Iii (Other) Buy 136,794 16.00 2,188,704
2018-07-02 Dyckerhoff Stefan A (Other) Buy 136,650 16.00 2,186,400
2018-07-02 Speiser Michael L (10% Owner) Buy 140,480 16.00 2,247,680
2018-07-02 Wheeler Kurt (10% Owner) Buy 200,000 16.00 3,200,000
2018-07-02 Bird Jeffrey W (Director) Buy 138,987 16.00 2,223,792
2018-07-02 Henner Dennis (Director) Buy 200,000 16.00 3,200,000
2018-07-02 White James N (10% Owner) Buy 142,150 16.00 2,274,400
2018-07-02 Coxe Tench (10% Owner) Buy 153,049 16.00 2,448,784
2018-07-02 Schaepe Christopher J (Director) Buy 468,750 16.00 7,500,000
2018-07-02 Sutter Hill Ventures (Other) Buy 134,735 16.00 2,155,760

Insider trading activities including stock purchases, stock sales, and option exercises of FTSV listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Forty Seven, Inc. (symbol FTSV, CIK number 1667633) see the Securities and Exchange Commission (SEC) website.